Revolution Medicines Inc (NASDAQ: RVMD) on Friday, plunged -3.58% from the previous trading day, before settling in for the closing price of $37.41. Within the past 52 weeks, RVMD’s price has moved between $15.44 and $38.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 11.11% annually for the last half of the decade. The company achieved an average annual earnings per share of 17.77%. With a float of $136.49 million, this company’s outstanding shares have now reached $164.67 million.
In an organization with 378 employees, it is important to assess its efficiency.
Revolution Medicines Inc (RVMD) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Revolution Medicines Inc is 17.13%, while institutional ownership is 79.18%. The most recent insider transaction that took place on Apr 10 ’24, was worth 353,346. In this transaction an insider of this company sold 10,000 shares at a rate of $35.33, taking the stock ownership to the 30,424 shares. Before that another transaction happened on Apr 10 ’24, when Company’s insider sold 7,500 for $35.48, making the entire transaction worth $266,122. This insider now owns 452,879 shares in total.
Revolution Medicines Inc (RVMD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.77% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Revolution Medicines Inc (RVMD) is currently performing well based on its current performance indicators. A quick ratio of 13.06 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 512.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.77, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -3.41 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Let’s dig in a bit further. During the last 5-days, its volume was 2.28 million. That was better than the volume of 1.4 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.36%. Additionally, its Average True Range was 1.82.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 85.40%, which indicates a significant increase from 71.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.35% in the past 14 days, which was higher than the 40.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.03, while its 200-day Moving Average is $28.00. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $37.63. Second resistance stands at $39.18. The third major resistance level sits at $40.39. If the price goes on to break the first support level at $34.86, it is likely to go to the next support level at $33.65. Assuming the price breaks the second support level, the third support level stands at $32.10.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
Market capitalization of the company is 5.94 billion based on 164,690K outstanding shares. Right now, sales total 11,580 K and income totals -436,370 K. The company made 740 K in profit during its latest quarter, and -161,540 K in sales during its previous quarter.
